Search for Sanofi and
    1. December 2, 2014

      Sanofi agrees €250m R&D outsourcing deal

      Sanofi of France has entered exclusive talks over a €250m drug discovery alliance with Evotec of Germany aimed at increasing...

    2. November 20, 2014

      Sanofi chairman lays bare tensions with ousted chief

      Sanofi’s chairman has issued a bullish defence of his decision to oust the French drugmaker’s chief executive last month and...

    Special Reports

    1. Combating Neglected Diseases

      While nobody questions the horror of the Ebola epidemic sweeping west Africa, the deat...
    2. Special Report: Doing Business in Lyon 2013

      Urban renewal is at the heart of ambitions to rise up the rankings in the economic pre...
    Search more Special Reports on this topic.

    1. October 31, 2014

      Sanofi chairman to roll sleeves up again after chief’s departure

      When Serge Weinberg started as Sanofi chairman in 2010, the French pharmaceuticals company looked to be hitting its stride....

    2. October 29, 2014

      ‘Style’ clash cited as Sanofi ousts Chris Viehbacher

      In 2008, Sanofi began looking for a new chief executive to guide the Paris-based drug company safely through what had all...

    3. October 29, 2014

      Sanofi board ousts chief executive Chris Viehbacher

      Sanofi’s directors ousted chief executive Chris Viehbacher calling his management style inadequate in the biggest shake-up...

    4. October 28, 2014

      Sanofi: finding the energy

      Diabetes disrupts the body’s metabolism, sapping it of the energy it needs. Its remedy, insulin, has recently had the same...

    5. October 28, 2014

      Sanofi shares tumble on fears over flat sales for diabetes drugs

      Sanofi said sales of its diabetes treatments would remain flat next year, sparking investor fears about the French group’s...

    6. October 16, 2014

      Pharma giants face developing market ambitions

      As the pharmaceuticals industry careered towards the edge of its notorious patent cliff over the past decade, there was one...

    7. October 9, 2014

      Sanofi hopes for substantial reward as dengue drug unveiled

      For big pharma, tackling neglected tropical diseases is a largely philanthropic enterprise – something done to demonstrate...

    8. beyondbrics

      August 21, 2014

      Legal hodge-podge frustrates Asean harmonisation

      Of all the colonial legacies left by Britain, France and the Netherlands in Asia, one of the least talked-about – yet...

    9. August 11, 2014

      Tesla powered higher by expansion plans

      Tesla shares approached an all-time high after brokerage Deutsche Bank lifted its rating on the electric car manufacturer to...

    10. August 6, 2014

      Sanofi’s success shows benefit of global approach in drugs R&D

      For reasons of prestige as much as profitability, every big pharmaceutical company wants to be known for expanding the...

    11. August 3, 2014

      Private equity eyes drug brands purchase

      Private equity groups are exploring a $10bn plan to buy hundreds of older drug brands from GlaxoSmithKline and Sanofi and...

    12. July 31, 2014

      Sanofi predicts ‘wave’ of new drug launches

      Upbeat Sanofi executives raised their full-year earnings guidance and predicted “a wave of new product launches” as the...

    13. June 8, 2014

      Chris Viehbacher shuns deal frenzy as Sanofi focuses on growth

      Chris Viehbacher is not someone who usually likes sitting on the sidelines. Known as a charismatic and dynamic leader, the...

    14. June 3, 2014

      Chief of French pharmaceuticals group Sanofi moves to US

      Sanofi scrambled to ease concern over its commitment to France on Tuesday after it was revealed that the company’s chief...

    15. April 29, 2014

      Sanofi chief executive touts organic growth strategy

      Megadeals are back in the pharmaceuticals industry but Sanofi plans to stay focused on organic growth and bolt-on...

    16. April 1, 2014

      Drugmakers learn to blend commerce with philanthropy in Africa

      Africa has rarely been a source of good publicity for big pharma. But two events this week suggest the drugs industry is...

    17. February 12, 2014

      L’Oréal to use up excess cash by paying dividends

      L’Oréal intends to continue increasing dividend payments as the principal way to use its cash, chief executive Jean-Paul...

    18. February 6, 2014

      Sanofi and AstraZeneca prove upbeat on range of new treatments

      AstraZeneca and Sanofi trumpeted progress towards a slew of new drugs for conditions ranging from arthritis to cancer on...

    19. December 16, 2013

      French police arrest 21 in illicit horsemeat inquiry

      French police have launched raids in southern France to halt the suspected trafficking into the food chain of horsemeat...

    20. November 14, 2013

      Drug manufacturers seek to expand the range of treatments

      Three companies have long dominated the commercial battle over insulin. For nearly a century since it was first developed,...

    21. October 30, 2013

      Sanofi: flu season

      Achoo! It is high season for flu vaccines. But you would not know it from the performance of the market leader. Sanofi’s net...

    22. October 30, 2013

      Sanofi cuts earning guidance as results miss expectations

      Vaccine shortages and slower emerging markets growth forced Sanofi to cut full-year earnings guidance as it reported...

    23. October 11, 2013

      Drug research: caring and sharing

      Which is more important – curing cancer, or malaria? Either will cost a fortune, take a long time to develop and benefit...

    24. October 2, 2013

      Johnson & Johnson: never say never

      Johnson & Johnson will never break up. Its focus on continuity is acute. The current boss has been at the company for 25...

    25. September 29, 2013

      Nestlé scrutinises its L’Oréal stake

      When Nestlé investors gather at the company’s Vevey headquarters for a two-day seminar on Monday, there will be one question...

    26. September 23, 2013

      Bribery claims infect drug companies’ dealings in China

      It began as a rumour on a Chinese social media site in July, but the impact has swiftly spread around the world: allegations...

    27. September 20, 2013

      Investment focus: Europe

      Global brands boost lure of continent Europe is finally showing signs of recovery, prompting analysts to suggest now is the...

    28. September 13, 2013

      Sanofi hints it could repurchase L’Oréal’s stake

      Sanofi, the French pharmaceuticals company, has hinted that it could repurchase L’Oréal’s 9 per cent stake in its shares if...

    29. September 4, 2013

      India approves $1.6bn acquisition of Agila Specialties by Mylan

      India’s government has given the go-ahead for US-based pharmaceutical company Mylan’s long-stalled $1.6bn acquisition of...

    30. August 30, 2013

      L’Oréal boss triggers talk of buying Nestlé’s €22bn stake

      L’Oréal tried to quash speculation that it could buy back a €22bn stake in the cosmetics maker from Swiss food group Nestlé,...

    31. August 26, 2013

      Italian stocks hit by fears of political uncertainty

      Italy’s FTSE MIB underperformed the broader pan-European FTSE Eurofirst 300 on Monday after renewed political uncertainty...

    32. August 14, 2013

      China widens probe into drug pricing and corruption

      Pressure on pharmaceutical companies operating in China intensified on Wednesday as mainland authorities announced a...

    33. August 11, 2013

      China begins probe into Sanofi whistleblower’s bribery claim

      Chinese authorities have launched an investigation into a whistleblower’s claim that staff at Sanofi bribed hospital...

    34. August 8, 2013

      Surgery needed to keep Novartis in shape

      The strength of Novartis is that it does what a big drug company should do: it makes original drugs that cure or ease the...

    35. August 8, 2013

      Novo Nordisk raises forecasts amid demand for diabetes treatments

      Novo Nordisk, the Nordic region’s most valuable company by market capitalisation, raised its sales and profit guidance for...

    36. August 8, 2013

      Chinese drugs industry inquiry widens

      Three more western pharmaceutical companies have been drawn into widening Chinese probes into pricing and marketing...

    37. August 1, 2013

      SocGen tops Eurofirst climbers on strong trading

      Société Générale topped pan-European indices after its second-quarter net profit more than doubled from a year ago thanks to...

    38. August 1, 2013

      Chinese officials visit Sanofi offices amid wider probes

      Chinese officials this week visited a regional office of Sanofi, the French pharmaceutical company, in the latest expansion...

    Search for Sanofi and